PECAM1 and cancer: Subsequently, we performed FACS detection of CAMs, and the results showed that cancer group cells had increased CD18 (ITGB2), CD106 (VCAM-1), and CD31 (PECAM-1), with decreased CD54 (ICAM-1) (Supplementary Fig. S2).